drugset / Trial / NCT02238535
Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess the effectiveness of the synthetic analogue of prostacyclin in postembolic residual pulmonary hypertension.
Timeline
- Start
- 2014-09
- Primary completion
- 2016-03
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iloprost | Other / unclassified | 2 ml | — |
| Comparator | Warfarin | Small molecule | — | — |